Dispatch Bio
Develops engineered immunotherapies for patients with solid tumors
Highlights
- New on EvolcAdded 2026-11-14
About Dispatch Bio
Dispatch Bio is developing the Flare platform, which combines immunotherapy with a tumor-specific virus to target solid tumors and address treatment resistance.
The company’s research and development facilities are in Philadelphia and San Francisco. Its team includes research, virology, clinical, and technical operations staff.
Product: The Flare platform, an engineered immunotherapy approach combining immunotherapy with a tumor-specific virus for solid tumors.
Jobs at Dispatch Bio
More biotech & pharma companies
Drug Hunter
Drug discovery intelligence and research tools for pharmaceutical scientists, drug discovery teams and investorsRemote-friendlyDyne Therapeutics
Targeted genetic therapies for people with genetically driven neuromuscular diseasesNew on EvolcDyno Therapeutics
AI-enabled genetic technology development for biotechnology and medicine developersNew on EvolcEarli
Develops genetic switches that activate in cancer cells for cancer detection and therapeutic applicationsNew on EvolcEditas Medicine
Develops CRISPR-based genomic medicines for people living with serious diseasesEisai
Research-based pharmaceutical company developing oncology and neurology medicines for patients and healthcare providersNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Frontend frameworks
- GatsbyMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Related technologyimplied by Gatsby
- Related technologyimplied by Gatsby
- Related technologyimplied by Gatsby
Hosting
- NetlifyHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-nf-request-id
- Response headerx-nf-request-id
- Response headerx-nf-request-id
Privacy & consent
- OsanoHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.